Nanobiotix (NBTX) Institutional Ownership $3.38 -0.02 (-0.59%) Closing price 03:54 PM EasternExtended Trading$3.40 +0.02 (+0.59%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Nanobiotix (NASDAQ:NBTX)CurrentInstitutional OwnershipPercentage38.81%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$273.78KNumber ofInstitutional Sellers(last 12 months)0 Get NBTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Nanobiotix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NBTX Institutional Buying and Selling by Quarter Remove Ads Nanobiotix Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Millennium Management LLC13,452$39K0.0%N/A0.029% 2/14/2025Jane Street Group LLC23,283$73K0.0%N/A0.049% 2/12/2025Geode Capital Management LLC10,184$29K0.0%N/A0.022% 2/12/2025OLD Mission Capital LLC48,474$139K0.0%N/A0.103% 1/26/2024Baillie Gifford & Co.2,869,030$20.89M0.0%+48.2%6.087% 11/13/2023Baillie Gifford & Co.1,936,195$16.94M0.0%+38.3%5.350% 11/9/2023Johnson & Johnson959,637$8.40M3.1%N/A2.652% 8/17/2021Woodline Partners LP59,994$827K0.0%-7.0%0.174% 5/18/2021Millennium Management LLC22,082$332K0.0%-53.3%0.066% 5/17/2021Perceptive Advisors LLC1,059,800$15.94M0.2%-3.7%3.043% 5/17/2021Woodline Partners LP64,514$970K0.0%-7.8%0.194% 5/12/2021UBS Group AG70,182$1.06M0.0%+20,183.8%0.211% (Data available from 1/1/2016 forward)Remove Ads NBTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NBTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Nanobiotix shares: Baillie Gifford & Co. ($20.89M), Johnson & Johnson ($8.40M), OLD Mission Capital LLC ($139K), Jane Street Group LLC ($73K), and Millennium Management LLC ($39K), Geode Capital Management LLC ($29K).Learn more on NBTX's institutional investors. What percentage of Nanobiotix stock is owned by institutional investors? 38.81% of Nanobiotix stock is owned by institutional investors. Learn more on NBTX's institutional investor holdings. Which institutional investors have been buying Nanobiotix stock? The following institutional investors have purchased Nanobiotix stock in the last 24 months: Baillie Gifford & Co. ($1.47M), Johnson & Johnson ($959.64K), OLD Mission Capital LLC ($48.47K), Jane Street Group LLC ($23.28K), Millennium Management LLC ($13.45K), and Geode Capital Management LLC ($10.18K). How much institutional buying is happening at Nanobiotix? Institutional investors have bought a total of 2,524,060 shares in the last 24 months. This purchase volume represents approximately $20.15M in transactions. Related Companies Prothena Institutional Ownership AbCellera Biologics Institutional Ownership Arbutus Biopharma Institutional Ownership ArriVent BioPharma Institutional Ownership CureVac Institutional Ownership ChromaDex Institutional Ownership Trevi Therapeutics Institutional Ownership Nuvation Bio Institutional Ownership Bicycle Therapeutics Institutional Ownership Immunome Institutional Ownership This page (NASDAQ:NBTX) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobiotix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
